AffiliationBreast Biology Group, School of Cancer and Enabling Sciences, Paterson Institute for Cancer Research, University of Manchester;, Manchester, United Kingdom.
MetadataShow full item record
AbstractWe and others have established that the developmental Notch receptor signaling pathway is active in breast cancer cell lines, as well as in preinvasive and invasive primary samples. Recently, a role for Notch in regulating the hierarchy of stem and progenitor cells in both normal and cancer epithelium has been elucidated. Because inhibiting the Notch receptor signaling pathway is a possible future breast cancer therapy, here, we review the expression and activity of the different ligands and receptors and summarize the various ways in which the pathway's activity can be inhibited, and the likely effects of inhibition on different tumor cell subpopulations.
CitationBreast cancer stem cells: something out of notching? 2010, 70 (22):8973-6 Cancer Res
- Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
- Authors: Grudzien P, Lo S, Albain KS, Robinson P, Rajan P, Strack PR, Golde TE, Miele L, Foreman KE
- Issue date: 2010 Oct
- Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
- Authors: Wang Z, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH
- Issue date: 2011 Apr
- Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications.
- Authors: Izrailit J, Reedijk M
- Issue date: 2012 Apr 28
- Targeting breast cancer stem cells.
- Authors: Wicha MS
- Issue date: 2009 Oct
- Rational targeting of Notch signaling in cancer.
- Authors: Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L
- Issue date: 2008 Sep 1